Enzymes that catalyze the first step of BCAA degradation, branched-chain aminotransferase 1 (BCAT1) and branched-chain aminotransferase 2 (BCAT2), are commonly upregulated in cancer cells. The gene discussed is BCAT2; the disease is cancer.